Multiple N-CoR Complexes Contain Distinct Histone Deacetylases*

Peter L. JonesDagger , Laurent M. SachsDagger §, Nicole RouseDagger §, Paul A. Wade||, and Yun-Bo ShiDagger **

From the Dagger  Unit of Molecular Morphogenesis, Laboratory of Molecular Embryology, NICHD, National Institutes of Health, Bethesda, Maryland 20892-5431 and the || Department of Pathology, Emory University, Woodruff Memorial Research Building, Atlanta, Georgia 30322

Received for publication, December 14, 2000, and in revised form, January 17, 2001


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

N-CoR (nuclear receptor corepressor) is a corepressor for multiple transcription factors including unliganded thyroid hormone receptors (TRs). In vitro, N-CoR can interact with the Sin3 corepressor, which in turn binds to the histone deacetylase Rpd3 (HDAC1), predicting the existence of a corepressor complex containing N-CoR, Sin3, and histone deacetylase. However, previous biochemical studies of endogenous Sin3 complexes have failed to find an N-CoR association. Xenopus laevis eggs and oocytes contain all of the necessary components for transcriptional repression by unliganded TRs. In this study, we report the biochemical fractionation of three novel macromolecular complexes containing N-CoR, two of which possess histone deacetylase activity, from Xenopus egg extract. One complex contains Sin3, Rpd3, and RbAp48; the second complex contains a Sin3-independent histone deacetylase; and the third complex lacks histone deacetylase activity. This study describes the first biochemical isolation of endogenous N-CoR-containing HDAC complexes and illustrates that N-CoR associates with distinct histone deacetylases that are both dependent and independent of Sin3. Immunoprecipitation studies show that N-CoR binds to unliganded TR expressed in the frog oocyte, confirming that N-CoR complexes are involved in repression by unliganded TR. These results suggest that N-CoR targets transcriptional repression of specific promoters through at least two distinct histone deacetylase pathways.


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Transcriptional regulation by many diverse groups of transcription factors, including nuclear hormone receptors, involves coactivator and corepressor complexes (reviewed in Refs. 1-3). N-CoR1 and SMRT (silencing mediator for retinoid and thyroid receptors) were initially characterized as highly homologous corepressors for unliganded TR (4, 5). Subsequently, N-CoR was identified as a Sin3 corepressor-binding protein (6, 7). This work suggested that N-CoR-mediated repression occurs through Sin3 recruitment of the Sin3-associated histone deacetylase Rpd3 (HDAC1), though an endogenous Sin3-containing N-CoR complex has never been described to date. However, recent work provides evidence that N-CoR can associate directly with HDAC4, HDAC5, and HDAC3, whereas SMRT can form a complex with HDAC5 and HDAC7, or with HDAC3 (8-12). These data suggest that multiple N-CoR-containing histone deacetylase complexes may exist to mediate transcriptional repression. We have previously demonstrated that the frog oocyte is capable of mediating both transcriptional activation by liganded TR and transcriptional repression by unliganded TR, indicating that the oocyte contains the necessary coactivator and corepressor complexes for TR (13-15). To characterize the corepressor complexes present in eggs and oocytes, we biochemically fractionated Xenopus egg extract and purified three distinct complexes. Our data also suggest that one or more of the N-CoR complexes participate in the repression by unliganded TR.

    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Chromatography-- Eggs were collected from mature female Xenopus laevis, and the high-speed egg extract was prepared exactly as described (16). All chromatography was carried out at 4 °C in Buffer A (20 mM HEPES, pH 7.6, 1.5 mM MgCl2, 1 mM EGTA, 10% glycerol, 10 mM beta -glycerophosphate, 0.5 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride, 2 µg/ml pepstatin A, 1 µg/ml aprotinin, and 1 µg/ml leupeptin). Egg extract was initially fractionated using BioRex70 resin (Bio-Rad) in Buffer A. The flow-through fraction was fractionated over DEAE-Sepharose (Amersham Pharmacia Biotech) with a step elution in Buffer A (to 350 mM NaCl). The DEAE (in 350 mM NaCl) step was further fractionated by linear salt gradient elution from Mono Q HR10/10 (Amersham Pharmacia Biotech). The peak N-CoR fractions were pooled and loaded directly onto a 110-ml Superose 6 (Amersham Pharmacia Biotech) gel filtration column in Buffer A (in 150 mM NaCl) with 0.04% Triton X-100. The peak N-CoR fractions were fractionated by linear salt gradient elution from Mono S HR5/5. The DEAE flow-through pool was fractionated on SP-Sepharose (Amersham Pharmacia Biotech) with a step elution in Buffer A (to 350 mM NaCl). The SP (350 mM) pool was fractionated using a linear salt gradient elution from a Mono Q HR5/5 (Amersham Pharmacia Biotech) column followed by gel filtration through Superose 6 as above. The SP-Sepharose flow-through fraction was fractionated over Mono Q 10/10 followed by gel filtration as above. The peak N-CoR fractions were further fractionated over Mono Q 5/5 as above.

Coimmunoprecipitations and Antibodies-- Either fractionated egg extract (100 µl fraction) or injected oocytes (40 oocytes/sample) were used as the protein sources. Antisera were conjugated to protein A-Sepharose (Amersham Pharmacia Biotech) with dimethyl pimelimidate (DMP) exactly as described (17). Coimmunoprecipitations were carried out in Buffer A (100 mM NaCl + 0.05% Nonidet P-40) at 4 °C for 60 min followed by a series of five washes in Buffer A (150 mM NaCl + 0.05% Nonidet P-40). Proteins were eluted with 100 mM glycine, pH 2.3, or used in the histone deacetylase assay described below. All coimmunoprecipitations were repeated at least three times. Rabbit polyclonal antibodies specific for Xenopus N-CoR were raised against a bacterially expressed N-terminal polypeptide (amino acids 34-272) derived from Xenopus N-CoR cDNA.2 Rabbit polyclonal antibodies raised against Xenopus TRbeta , Sin3, Rpd3, and RbAp48 have been described (13, 34). HDAC5 antibody was a generous gift from S. Khochbin (19). HDAC3 antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA).

Histone Deacetylase Assay-- Histone deacetylase assays were performed as described (16). Chicken erythrocyte core histones enzymatically acetylated ([3H]acetyl-CoA) with recombinant yeast Hat1p were used as the substrate (20). Reactions were carried using 25 µl of each fraction in 25 mM Tris, pH 8.0, 50 mM NaCl, 1 mM EDTA, 10% glycerol, and 2 µg of acetylated histones (400-µl final volume). The reactions were incubated at 30 °C for 60 min and terminated with 100 µl of stop solution (0.1 N HCl and 0.16 N acetic acid). Released acetate was extracted with ethyl acetate (800 µl), and 75% of the organic phase was counted by liquid scintillation. Experiments were repeated at least three times.

Microinjection of Oocytes-- Oocyte preparation and microinjections were carried out as described (18). Oocytes were injected with 3 ng in vitro transcribed capped RNA (Ambion Inc.) encoding Xenopus TRbeta and or RXRalpha . Injected oocytes were incubated for 16 h at 18 °C with or without thyroid hormone (50 nM T3) prior to homogenization in Buffer A (100 mM NaCl).

    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

We used X. laevis high speed egg extracts as the source for soluble endogenous proteins to biochemically purify endogenous complexes containing the N-CoR transcriptional corepressor. The extract was initially fractionated over BioRex70 resin, which bound over 90% of the Sin3 corepressor protein present in eggs (data not shown). Surprisingly, all of the detectable N-CoR was contained in the flow-through fraction (data not shown). Size fractionation (Sephacryl S-300) of the BioRex70 flow-through pool demonstrated that all of the N-CoR existed in large complexes (>669 kDa) with no detectable free N-CoR (270 kDa, Fig. 1A). Further fractionation of the BioRex70 flow-through protein pool over DEAE-Sepharose separated the N-CoR into two distinct pools. Roughly 50% of the N-CoR bound to the DEAE (complex 1) and 50% remained in the flow-through fraction (Fig. 1B). Fractionation of the DEAE flow-through pool over SP-Sepharose again separated the N-CoR into a bound pool (complex 2) and a flow-through pool (complex 3, Fig. 1B). Extensive purification of all three of the N-CoR protein pools was achieved through a series of ion exchange and gel filtration chromatographic steps as outlined in Fig. 1D. Size fractionation of the purified complexes through Superose 6 showed that all three N-CoR complexes continued to migrate in the MDa range (data not shown), supporting the observation that the three N-CoR protein pools are in fact distinct macromolecular complexes and not dissociation products. A summary of a typical purification is presented in Table I.


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 1.   Biochemical fractionation of Xenopus egg extract reveals three distinct N-CoR complexes. A, all of the N-CoR in Xenopus egg extracts exists in high molecular weight complexes as determined by sizing fractionation of the BioRex70 flow-through fraction through Sephacryl S-300 resin. Selected fractions from resin were analyzed on Western blot using anti-Xenopus N-CoR antibody. B, Western blot analysis with anti-Xenopus N-CoR antibody on initial steps of fractionation indicate that Xenopus N-CoR exists in three complexes that can be distinguished by ion exchange chromatography over DEAE and SP-Sepharose. C, DEAE step fractionation of the BioRex70 flow-through separates N-CoR into Sin3-dependent (elution) and Sin3-independent (flow-through) fractions. Western blot analysis on the DEAE step fractionation, using antibodies against the proteins indicated on the right, shows the partitioning of Sin3/Rpd3-containing fractions. D, flow chart of the N-CoR purification scheme summarizes the chromatographic procedures described in the text.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Protein recovery data for the purification of N-CoR complexes

The polypeptide profiles of the three N-CoR complexes were determined by silver-staining SDS-PAGE separations of the final step of fractionation. These results showed that each complex was largely pure and consisted of multiple distinct polypeptides (Fig. 2). Complex 1 contains eight polypeptides, whereas complex 2 and complex 3 each contain four polypeptides. Because N-CoR can interact with Sin3, and Sin3 can interact with Rpd3, we assayed the presence of the Sin3 and Rpd3 proteins as well as histone deacetylase activity in the three N-CoR complexes. Western blot analyses of the final steps of the purifications identified complex 1 as containing Sin3 (p150) and Rpd3 (p58) whereas neither complex 2 nor complex 3 contained either Sin3 or Rpd3 (Fig. 2, B and C). Interestingly, histone deacetylase activity was found to precisely cofractionate with the N-CoR protein for both complexes 1 and 2 (Fig. 3, A and B). These data indicate that complex 2 possesses a Sin3-independent histone deacetylase. Complex 3 contained no detectable histone deacetylase activity (Fig. 3C). Because N-CoR complexes 1 and 2 each contained histone deacetylase activity, we tested for the presence of RbAp48, a protein that binds to the retinoblastoma A tumor suppressor and has been found in several histone deacetylase complexes (Refs. 21-25). We found that RbAp48 was present in complex 1 but absent in complexes 2 and 3 (Fig. 2). Thus, complex 1 contains the predicted N-CoR complex components, mainly N-CoR, Rpd3, Sin3, and RbAp48, whereas complexes 2 and 3 are novel and do not appear to share any subunits with complex 1. 


View larger version (33K):
[in this window]
[in a new window]
 
Fig. 2.   The purified N-CoR complexes contain multiple subunits. Fractions from the final purification step shown in Fig. 1 for complex 1 (A), complex 2 (B), and complex 3 (C) were resolved on SDS-polyacrylamide gel electrophoresis and analyzed by silver staining (upper panels) or by Western blotting (lower panels). Multiple polypeptides were found to be present in each complex (polypeptides that do not precisely cofractionate are considered nonspecific and are denoted by an asterisk). Western blotting analysis using specific antibodies identified N-CoR in all three complexes and Sin3, Rpd3, and RbAp48 in complex 1.


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 3.   N-CoR complex 1 and complex 2 contain histone deacetylase activity. Fractions, as shown in Fig. 2, were assayed for histone deacetylase activity. Activity precisely copurified with N-CoR protein for complex 1 (A), and complex 2 (B). Complex 3 (C) lacked any detectable HDAC activity. Fraction numbers correspond to those shown in Fig. 2.

To confirm the physical associations between N-CoR and the known components of the complexes, we performed coimmunoprecipitation experiments (Fig. 4). Immunoprecipitation reactions were carried out using antiserum against N-CoR, Sin3, or Rpd3 as the precipitating antibodies. Xenopus egg extract fractionated through the DEAE step, which separates complex 1 from complexes 2 and 3 (Fig. 1B), was used as the protein source. The precipitation products were assayed by either Western blot analysis using the N-CoR antibody (Fig. 4A) or by histone deacetylase assay (Fig. 4B). Reactions using either the Sin3, N-CoR, or Rpd3 antibodies as the precipitating antibody all immunoprecipitated N-CoR protein when the DEAE-0.35 M step elution (containing complex 1; Fig. 4A, top panel) was used as the protein source (Fig. 4A, lanes 2-4). However, when the DEAE flow-through fraction (containing complexes 2 and 3; Fig. 4A, lower panel) was used as the protein source, only the N-CoR antibody immunoprecipitated N-CoR protein, whereas the Sin3 and Rpd3 antibodies failed to immunoprecipitate any detectable N-CoR protein (Fig. 4A, lanes 7-8). These data confirm the association of N-CoR with Sin3 and Rpd3 in complex 1 as well as the lack of association between N-CoR and Sin3 or Rpd3 in complexes 2 and 3. For both the DEAE elution and flow-through fractions, an irrelevant antibody (Irr) failed to immunoprecipitate N-CoR protein (Fig. 4A, lanes 5 and 10). In addition, antibodies against N-CoR specifically immunoprecipitated histone deacetylase activity from both protein pools (Fig. 4B). These data support the existence of at least two independent multisubunit N-CoR/histone deacetylase complexes. In addition, these results show a physical association of N-CoR with Sin3, Rpd3, and HDAC activity in complex 1 (but not in complexes 2 or 3) and N-CoR with HDAC activity in complex 2. 


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 4.   N-CoR complex 1 and complex 2 stably associate with histone deacetylase activity and corepressor proteins. A, the DEAE-0.35 M step elution fraction (upper panel) or the DEAE flow-through fraction (lower panel), as described in Fig. 1, were immunoprecipitated with antibodies raised against N-CoR, Sin3, Rpd3, an irrelevant antibody (Irr), or unconjugated protein A-Sepharose (Control) as indicated above the panels. The precipitation products were assayed by Western blotting for the presence of N-CoR protein. (B) The immunoprecipitate products obtained with the N-CoR antibody or an irrelevant antibody (Irr) as described in A were assayed for histone deacetylase activity. The -fold HDAC activity was calculated as the released cpm from the experimental sample divided by the released cpm from a negative control containing no starting protein.

We have shown previously that unliganded TRbeta represses target promoters in frog oocytes and that this repression can be reversed by blocking HDAC activity (15). To investigate if any of the N-CoR complexes participate in this repression, we overexpressed TRbeta and its heterodimer partner RXRalpha (9-cis retinoic acid receptor) by microinjecting in vitro transcribed mRNA into frog oocytes and analyzing associations with N-CoR. Immunoprecipitation experiments using antibodies against TRbeta (Fig. 5A) indicate that TRbeta /RXRalpha heterodimers (lanes 2 and 3), as well as TRbeta homodimers (lanes 4 and 5) interact with endogenous N-CoR in a thyroid hormone (T3)-dependent manner. Immunoprecipitation experiments using precipitating antibodies against N-CoR (Fig. 5B) confirm a ligand-dependent interaction between N-CoR and TRbeta (lanes 2-5).


View larger version (34K):
[in this window]
[in a new window]
 
Fig. 5.   TR interacts with N-CoR in vivo in a ligand-dependent manner. Xenopus oocytes were microinjected (+) with in vitro transcribed mRNAs encoding TRbeta , RXRalpha , or both. The oocytes were incubated with or without T3 (50 nM) as indicated. Oocyte extracts prior to immunoprecipitation were analyzed by Western blotting for the expression of proteins encoded by injected mRNAs (Input Control). The rest of the oocyte extracts were precipitated with antibodies specific for either TRbeta (A) or N-CoR (B). Uninjected oocytes, which lacked any detectable TRbeta or RXRalpha protein, were used as controls (A and B, lane 1). The precipitation products were assayed by Western blotting for N-CoR (A and B, upper panel) and TRbeta (B, middle panel).


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

N-CoR was initially characterized as a corepressor for unliganded TRs; however, it has been shown to participate in transcriptional repression through other transcription factors (reviewed in Refs. 2 and 26). Mice lacking N-CoR have multiple developmental defects and show that N-CoR is required for the repressive effects of several classes of DNA-binding transcriptional repressors (27). How N-CoR is differentially targeted to these transcription factors in vivo is unknown. N-CoR-mediated repression has been shown to involve the mSin3 corepressor and histone deacetylase activities (6, 7). However, mSin3 complexes containing N-CoR have so far eluded biochemical purification (28-30). We have purified two N-CoR/histone deacetylase complexes from Xenopus eggs and one N-CoR complex of unknown biological activity. All three N-CoR complexes are very large in size (>MDa) and consist of multiple polypeptides.

Two of the N-CoR complexes clearly have histone deacetylase activity (Fig. 3, A and B); however, the absence of Rpd3 (HDAC1) in N-CoR complex 2 suggested the presence of alternative histone deacetylases. Currently, seven histone deacetylases have been found in mammals that are separated into two different classes based on amino acid homology; class I contains Rpd3 (HDAC1), HDAC2, and HDAC3 whereas class II contains HDAC4-7 (9, 18, 31-33). Data from other systems indicate that N-CoR interacts with multiple HDACs including both class I and class II (8, 11, 12). These HDAC proteins are generally well conserved during evolution, making it feasible to use heterologous antibodies to check for the presence of various HDACs in the frog complexes despite the lack of sequence information on frog HDAC2-7. We obtained antibodies raised against mammalian HDAC3, 4, and 5 for Western blot analysis of the purified complexes. Only antibodies against HDAC3 and HDAC5 detected polypeptides of similar size as their mammalian homologs (Fig. 1C). However, Western blot analysis of the purified complexes with the HDAC3 and HDAC5 antibodies indicated that neither HDAC3 nor HDAC5 was present in any of the complexes (data not shown). Thus, whereas complex 1 contains Rpd3 (HDAC1), complex 2 clearly does not contain Rpd3 (HDAC1, Fig. 2B). However, we cannot rule out or identify any of the other HDACs with the available reagents.

In addition to having distinct polypeptide compositions, visualization by silver staining (assuming equivalent staining sensitivities among all of the various polypeptides) revealed that the three N-CoR complexes do not appear to have a 1:1 stoichiometry among all of the associated polypeptides in relation to N-CoR (Fig. 2). In complex 1, six of the eight polypeptides appear to be in a 1:1 ratio with N-CoR, whereas Rpd3 (2:1) and RbAp48 (4:1) are clearly more abundant. The resulting mass of complex 1 is predicted to be slightly more than 1 MDa. The multiple copies of Rpd3 and RbAp48 in the complex may suggest their functions as the catalytic subunit and a histone-interacting subunit, respectively. The four subunits of complex 2 (N-CoR, p115, p60, and p52), appear to have a stoichiometry of 1:1:2:4 respectively. It is possible that the complex exists as a multimer in vivo as the mass of the complex is greater than 1 MDa when assayed by gel filtration chromatography even though the sum of the polypeptides is only 700 kDa. Complex 3 also consists of four polypeptides (N-CoR, p120, p65, and p29), with a stoichiometry of 2:3:1:1, respectively, predicting a mass of 1 MDa. The role of the multiple subunits may indicate that the complexes must interact with multiple targeting proteins or additional corepressor complexes in vivo. Clearly, further studies on the exact stoichiometry of these complexes and their biochemical and molecular properties are required to determine their biological functions and mechanisms.

The ability of unliganded TRs to repress gene transcription in the frog oocyte in a histone deacetylase-dependent manner together with our isolation of two N-CoR-containing histone deacetylase complexes argues that one or more of these complexes participates in the repression process. This conclusion is supported by the interaction of overexpressed TRbeta with N-CoR in the frog oocytes, where all of the N-CoR is present in large complexes. Whereas the functional differences among these complexes remain to be investigated, our findings provide an explanation for some inconsistent earlier observations. First, N-CoR was initially shown to interact with Rpd3 (HDAC1) through mSin3, but N-CoR/mSin3/Rpd3 complexes have eluded biochemical purification in vivo. Second, N-CoR has been shown to be able to interact with both class I and class II histone deacetylases in vitro and form complexes with them in vivo (8, 9, 11, 12). The nature of such complexes is yet unknown; however, all are independent of mSin3A. Our results here demonstrate that these possibilities coexist in vivo. The failure of other studies to detect the multiple complexes is likely because of the choice of the systems and the purification procedures, which we found to be crucial for the separation and isolation of the three complexes. It is also worth noting that our procedure allowed us to successfully purify the first complex that contains Sin3, Rpd3 (HDAC1), and RbAp48 together. Extensive studies including coimmunoprecipitations have demonstrated pairwise associations between mSin3A, Rpd3 (HDAC1), and RbAp48, suggesting that the three proteins may exist together in a complex. However, until our study here, such a complex had eluded purification.

Our data here provide a potential mechanism whereby N-CoR complexes are differentially recruited by specific transcriptional regulators to repress target genes. An additional level of regulation may come from changes in the ratio among the various N-CoR complexes or from alterations in subunit concentrations. These findings provide an opportunity to investigate these possible mechanisms in the near future.

    FOOTNOTES

* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ These authors contributed equally to this work.

Present address: Laboratoire de Physiologie, MNHN, UMR CNRS 8572, 7 rue Cuvier, 75231 PARIS cedex 05, France.

** To whom correspondence should be addressed: UMM, LME, NICHD, National Institutes of Health, Bldg. 18T, Rm. 106, Bethesda, MD 20892-5431. Tel.: 301-402-1004; Fax: 301-402-1323; E-mail: Shi@helix.nih.gov.

Published, JBC Papers in Press, January 19, 2001, DOI 10.1074/jbc.C000879200

2 L. M. Sachs, P. L. Jones, N. Rouse, and Y-B. Shi, manuscript in preparation.

    ABBREVIATIONS

The abbreviations used are: N-CoR, nuclear receptor corepressor; HDAC, histone deacetylase; T3, triiodothyronine; TR, thyroid hormone receptor.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1. Imhof, A., and Wolffe, A. P. (1998) Curr. Biol. 8, R422-424[Medline] [Order article via Infotrieve]
2. Collingwood, T. N., Urnov, F. D., and Wolffe, A. P. (1999) J. Mol. Endocrinol. 23, 255-275[Abstract/Free Full Text]
3. Hu, I., and Lazar, M. A. (2000) Trends Endocrinol. Metab. 11, 6-10[CrossRef][Medline] [Order article via Infotrieve]
4. Horlein, A. J., Naar, A. M., Heinzel, T., Torchia, J., Gloss, B., Kurokawa, R., Ryan, A., Kamei, Y., Soderstrom, M., Glass, C. K., and Rosenfeld, M. G. (1995) Nature 377, 397-404[CrossRef][Medline] [Order article via Infotrieve]
5. Chen, J. D., and Evans, R. M. (1995) Nature 377, 454-457[CrossRef][Medline] [Order article via Infotrieve]
6. Alland, L., Muhle, R., Hou, H., Jr., Potes, J., Chin, L., Schreiber-Agus, N., and DePinho, R. A. (1997) Nature 387, 49-55[CrossRef][Medline] [Order article via Infotrieve]
7. Heinzel, T., Lavinsky, R. M., Mullen, T. M., Soderstrom, M., Laherty, C. D., Torchia, J., Yang, W. M., Brard, G., Ngo, S. D., Davie, J. R., Seto, E., Eisenman, R. N., Rose, D. W., Glass, C. K., and Rosenfeld, M. G. (1997) Nature 387, 43-48[CrossRef][Medline] [Order article via Infotrieve]
8. Wen, Y. D., Perissi, V., Staszewski, L. M., Yang, W. M., Krones, A., Glass, C. K., Rosenfeld, M. G., and Seto, E. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 7202-7207[Abstract/Free Full Text]
9. Kao, H. Y., Downes, M., Ordentlich, P., and Evans, R. M. (2000) Genes Dev. 14, 55-66[Abstract/Free Full Text]
10. Guenther, M. G., Lane, W. S., Fischle, W., Verdin, E., Lazar, M. A., and Shiekhattar, R. (2000) Genes Dev. 14, 1048-1057[Abstract/Free Full Text]
11. Huang, E. Y., Zhang, J., Miska, E. A., Guenther, M. G., Kouzarides, T., and Lazar, M. A. (2000) Genes Dev. 14, 45-54[Abstract/Free Full Text]
12. Li, J., Wang, J., Nawaz, Z., Liu, J. M., Qin, J., and Wong, J. (2000) EMBO J. 19, 4342-4350[Abstract/Free Full Text]
13. Wong, J., Shi, Y. B., and Wolffe, A. P. (1995) Genes Dev. 9, 2696-2711[Abstract]
14. Wong, J., Shi, Y. B., and Wolffe, A. P. (1997) EMBO J. 16, 3158-3171[Abstract/Free Full Text]
15. Wong, J., Patterton, D., Imhof, A., Guschin, D., Shi, Y. B., and Wolffe, A. P. (1998) EMBO J. 17, 520-534[Abstract/Free Full Text]
16. Wade, P. A., Jones, P. L., Vermaak, D., and Wolffe, A. P. (1998) Methods Enzymol.
17. Harlow, E., and Lane, D. (1999) Using Antibodies: a Laboratory Manual , pp. 321-325, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N. Y
18. Fischle, W., Emiliani, S., Hendzel, M. J., Nagase, T., Nomura, N., Voelter, W., and Verdin, E. (1999) J. Biol. Chem. 274, 11713-11720[Abstract/Free Full Text]
19. Lemercier, C., Verdel, A., Galloo, B., Curtet, S., Brocard, M. P., and Khochbin, S. (2000) J. Biol. Chem. 275, 15594-15599[Abstract/Free Full Text]
20. Parthun, M. R., Widom, J., and Gottschling, D. E. (1996) Cell 87, 85-94[Medline] [Order article via Infotrieve]
21. Qian, Y. W., Wang, Y. C., Hollingsworth, R. E., Jr., Jones, D., Ling, N., and Lee, E. Y. (1993) Nature 364, 648-652[CrossRef][Medline] [Order article via Infotrieve]
22. Nicolas, E., Morales, V., Magnaghi-Jaulin, L., Harel-Bellan, A., Richard-Foy, H., and Trouche, D. (2000) J. Biol. Chem. 275, 9797-9804[Abstract/Free Full Text]
23. Wade, P. A., Jones, P. L., Vermaak, D., and Wolffe, A. P. (1998) Curr. Biol. 8, 843-846[Medline] [Order article via Infotrieve]
24. Zhang, Y., LeRoy, G., Seelig, H. P., Lane, W. S., and Reinberg, D. (1998) Cell 95, 279-289[Medline] [Order article via Infotrieve]
25. Zhang, Y., Iratni, R., Erdjument-Bromage, H., Tempst, P., and Reinberg, D. (1997) Cell 89, 357-364[Medline] [Order article via Infotrieve]
26. Glass, C. K., and Rosenfeld, M. G. (2000) Genes Dev. 14, 121-141[Free Full Text]
27. Jepsen, K., Hermanson, O., Onami, T. M., Gleiberman, A. S., Lunyak, V., McEvilly, R. J., Kurokawa, R., Kumar, V., Liu, F., Seto, E., Hedrick, S. M., Mandel, G., Glass, C. K., Rose, D. W., and Rosenfeld, M. G. (2000) Cell 102, 753-763[Medline] [Order article via Infotrieve]
28. Hassig, C. A., Fleischer, T. C., Billin, A. N., Schreiber, S. L., and Ayer, D. E. (1997) Cell 89, 341-347[Medline] [Order article via Infotrieve]
29. Laherty, C. D., Billin, A. N., Lavinsky, R. M., Yochum, G. S., Bush, A. C., Sun, J. M., Mullen, T. M., Davie, J. R., Rose, D. W., Glass, C. K., Rosenfeld, M. G., Ayer, D. E., and Eisenman, R. N. (1998) Mol. Cell 2, 33-42[Medline] [Order article via Infotrieve]
30. Jones, P. L., Veenstra, G. J., Wade, P. A., Vermaak, D., Kass, S. U., Landsberger, N., Strouboulis, J., and Wolffe, A. P. (1998) Nat. Genet. 19, 187-191[CrossRef][Medline] [Order article via Infotrieve]
31. Rundlett, S. E., Carmen, A. A., Kobayashi, R., Bavykin, S., Turner, B. M., and Grunstein, M. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 14503-14508[Abstract/Free Full Text]
32. Yang, W. M., Yao, Y. L., Sun, J. M., Davie, J. R., and Seto, E. (1997) J. Biol. Chem. 272, 28001-28007[Abstract/Free Full Text]
33. Grozinger, C. M., Hassig, C. A., and Schreiber, S. L. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 4868-4873[Abstract/Free Full Text]
34. Vermaak, D., Wade, P. A., Jones, P. L., Shi, Y.-B., and Wolffe, A. P. (1999) Mol. Cell. Biol. 19, 5847-5860[Abstract/Free Full Text]


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.